Issued (in shares) Class Of Warrant Or Right, Issued In Period Class Of Warrant Or Right, Issued In Period Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Jay Venkatesan and Trusts Affiliated With Jay Venkatesan Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member] Jay Venkatesan and Trusts Affiliated With Jay Venkatesan Award Timing Predetermined Award Timing Predetermined [Flag] Related Party Transaction [Axis] Related Party Transaction [Axis] 2026 (remaining nine months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Ownership maximum (as a percent) Class of Warrant or Right, Ownership Percent Maximum Class of Warrant or Right, Ownership Percent Maximum Recently Adopted Accounting Standards During the Period and Recently Issued Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Accounts payable Increase (Decrease) in Accounts Payable January Offering January Offering [Member] January Offering Reportable Segment Reportable Segment [Member] Reportable Segment Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Pre-funded warrants outstanding (in shares) Number of warrants outstanding (in shares) Class of Warrant or Right, Outstanding Net loss per common share, basic (in dollars per share) Net loss per share, basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Related Party Transactions Related Party Transactions Disclosure [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Employee related research and development expenses Employee Related Reasearch and Development [Member] Employee Related Reasearch and Development Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Liabilities, Fair Value Disclosure [Abstract] Liabilities, Fair Value Disclosure [Abstract] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Issuance of common stock upon settlement of restricted stock and common warrants (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures July Pre-Funded Warrants and July Common Warrants July Pre-Funded Warrants and July Common Warrants [Member] July Pre-Funded Warrants and July Common Warrants Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Elicio Warrants Elicio Warrants [Member] Elicio Warrants Measurement Input Type [Domain] Measurement Input Type [Domain] Adjustment to Compensation, Amount Adjustment to Compensation Amount Angion Common Stock Angion Common Stock [Member] Angion Common Stock Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Weighted average strike price Measurement Input, Strike Price [Member] Measurement Input, Strike Price Stock Option Shares issuable upon exercise of stock options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Professional fees and other general and administrative expenses Other General and Administrative Expense Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Number of research grant agreements Number Of Research Grant Agreements Number Of Research Grant Agreements Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total stockholders' (deficit) equity Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Stock-based compensation expense Share-Based Payment Arrangement, Expense Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Research Grants Research, Development, and Computer Software Disclosure [Text Block] Issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Current assets Assets, Current [Abstract] Forfeited (unvested) (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity (deficit) Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Number of Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Liabilities and stockholders’ equity (deficit) Liabilities and Equity [Abstract] Cover [Abstract] Money market funds Cash and Cash Equivalents, Fair Value Disclosure Conversion of Stock, Name [Domain] Conversion of Stock, Name [Domain] Maximum Maximum [Member] General and administrative General and Administrative Expense [Member] Options vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Accounting Policies [Abstract] July Share And July Common Warrant July Shares And July Common Warrant [Member] July Shares And July Common Warrant Schedule of Maturities of Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Unvested shares under restricted stock grants Restricted Stock [Member] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Treasury Stock Treasury Stock, Common [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Operating lease liabilities Operating Lease, Liability Foreign currency translation adjustment Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Warrant Liability Warrant Liability [Member] Warrant Liability Entity Shell Company Entity Shell Company Warrant liabilities Warrant Liability Warrant Liability Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Stockholders' (deficit) equity: Statement of Stockholders' Equity [Abstract] Inducement 2024 Plan Inducement 2024 Plan [Member] Inducement 2024 Plan Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Measurement Input Type [Axis] Measurement Input Type [Axis] Name Measure Name Accrued interest Accrued Interest Accrued Interest Schedule of Components of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Operating lease liability, current Less: operating lease liability, current portion Operating Lease, Liability, Current Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Class of Stock [Line Items] Class of Stock [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus Award Timing Method Award Timing Method [Text Block] Furniture and fixtures Furniture and Fixtures [Member] Award Type [Axis] Award Type [Axis] Legal Entity [Axis] Legal Entity [Axis] Total assets Total segment assets Assets Commitments and Contingencies Disclosure [Line Items] Commitments and Contingencies Disclosure [Line Items] Commitments and Contingencies Disclosure Trading Symbol Trading Symbol 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Geographical [Domain] Geographical [Domain] At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable Noncash Or Part Noncash Acquisition, At-the-market Offering Costs Incurred But Not Paid Noncash Or Part Noncash Acquisition, At-the-market Offering Costs Incurred But Not Paid Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Other segment items(1) Segment Reporting, Other Segment Item, Amount Effect of foreign currency on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Royalty rates (as a percent) Royalty Rate, Percent Royalty Rate, Percent Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Assets, Fair Value Disclosure [Abstract] Assets, Fair Value Disclosure [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Shares issuable upon the exercise of warrants (excluding pre-funded warrants) Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Restricted cash Restricted Cash and Cash Equivalent Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Common Stock, Shares, Outstanding Change in fair value of warrant liabilities Change in fair value of warrant liabilities Fair Value Adjustment of Warrants July 2024 Common Warrants One July Common Warrant One [Member] July Common Warrant One Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Interest income Investment Income, Interest Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Issuance of common stock upon exercise of options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Total prepaid and other current assets Prepaid Expense and Other Assets, Current Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Weighted Average Remaining Contractual Life (years) Class of Warrant or Right, Weighted Average Remaining Contractual Terms Class of Warrant or Right, Weighted Average Remaining Contractual Terms Reimbursement from grant funds Research And Development Arrangement, Reimbursement from Grant Funds Research And Development Arrangement, Reimbursement from Grant Funds Share-Based Payment Arrangement [Abstract] Cash, cash equivalents and restricted cash at the beginning of the period Cash, cash equivalents, and restricted cash at the end of the period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income tax provision (benefit) Income Tax Expense (Benefit) Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Sale of Stock [Domain] Sale of Stock [Domain] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Dividend yield (per share) Measurement Input, Expected Dividend Rate [Member] Clinical trial expenses Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Total property and equipment Property, Plant and Equipment, Gross Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total liabilities Liabilities, Fair Value Disclosure Organization, Consolidation and Presentation of Financial Statements [Abstract] Other (expense) income Other Income and Expenses [Abstract] Amortization of right-of-use assets, operating leases Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Proceeds from the exercise of stock options Proceeds from Stock Options Exercised City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Debt instrument, prepayment fee prepaid (as a percent) Debt Instrument, Redemption Price, Percentage Accrued expenses Total accrued expenses Accrued Liabilities, Current Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Other research and development expenses Other [Member] Other Accrued clinical trial and research and development costs Accrued Clinical Trial And Research And Development Costs, Current Accrued Clinical Trial And Research And Development Costs, Current General and administrative Employee related general and administrative expenses General and Administrative Expense Unrecognized compensation related to unvested stock option awards Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Warrants And Rights Outstanding [Abstract] Warrants And Rights Outstanding At-The-Market Equity Offering Sales Agreement 2026 At-The-Market Equity Offering Sales Agreement 2026 [Member] At-The-Market Equity Offering Sales Agreement 2026 Related Party Transactions [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Schedule of Black-Scholes Option-Pricing Model Following Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Depreciation Depreciation Debt Instrument, Redemption, Period Three Debt Instrument, Redemption, Period Three [Member] Numerator Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Aggregate sales milestone payments per product Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Research and Development, Contract to Perform for Others [Table] Equity Components [Axis] Equity Components [Axis] Entity Ex Transition Period Entity Ex Transition Period Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Convertible Notes Payable Convertible Debt [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Operating expenses: Operating Costs and Expenses [Abstract] Number of reportable segments Number of Reportable Segments Equipment Equipment [Member] Debt discount Debt Instrument, Unamortized Discount (Premium), Net GKCC GKCC [Member] GKCC Warrants, contractual term (in years) Warrants and Rights Outstanding, Term Supplemental disclosure of noncash investing and financing activities: Supplemental Cash Flow Information [Abstract] Other Performance Measure, Amount Other Performance Measure, Amount Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province Clinical trial expenses Clinical Trail [Member] Clinical Trail Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Boston, Massachusetts Boston, Massachusetts [Member] Boston, Massachusetts Total current liabilities Liabilities, Current Individual: Individual [Axis] June 2025 Warrants June 2025 Warrants [Member] June 2025 Warrants Research and development Research and Development Expense [Member] Entity [Domain] Entity [Domain] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Future minimum annual maintenance payments Collaborative Arrangement, Future Minimum Maintenance Payments Collaborative Arrangement, Future Minimum Maintenance Payments Project [Domain] Project [Domain] Other long-term prepaid assets Prepaid Expense Other, Noncurrent Operating lease, right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current 2026 Registration Statement 2026 Registration Statement [Member] 2026 Registration Statement Plan Name [Domain] Plan Name [Domain] June 2025 Common Warrants June 2025 Common Warrants [Member] June 2025 Common Warrants Unrecognized compensation related to unvested stock option awards, period for recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Exercise of stock options (in shares) Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Equity [Abstract] Equity [Abstract] Options vested and exercisable, total intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Segment Reporting Segment Reporting Disclosure [Text Block] University University [Member] University Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Weighted Average Weighted Average [Member] Volatility (annual) Measurement Input, Price Volatility [Member] Angion Warrants Angion Warrants [Member] Angion Warrants Entity Central Index Key Entity Central Index Key Contract and grant reimbursements Recovery of Direct Costs PEO Name PEO Name Net proceeds Sale of Stock, Consideration Received on Transaction Stock Conversion Description [Axis] Stock Conversion Description [Axis] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Payment of offering costs for the issuance of common stock from at-the-market offering Payment Of Offering Costs For The Issuance Of Common Stock From At-The-Market Offering Payment Of Offering Costs For The Issuance Of Common Stock From At-The-Market Offering Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Balance, beginning of the period Balance, end of the period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Advanced professional fees Advanced Professional Fees Advanced Professional Fees Segments [Axis] Segments [Axis] Exercise price (in dollars per share) Weighted average exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Accrued expenses Increase (Decrease) In Accrued Expenses Increase (Decrease) In Accrued Expenses Assets Assets [Abstract] Long-term debt, net Long-Term Debt, Excluding Current Maturities Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Debt Instrument [Axis] Debt Instrument [Axis] RSUs forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value Measurements Fair Value Disclosures [Text Block] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Research and Development [Abstract] Entity Address, Address Line One Entity Address, Address Line One Research and development Research and Development Expense At-The-Market Equity Offering Sales Agreement 2024 At-The-Market Equity Offering Sales Agreement 2024 [Member] At-The-Market Equity Offering Sales Agreement 2024 Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Stated interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Operating lease liability, noncurrent Operating Lease, Liability, Noncurrent Conversion of senior note payable into common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Royalty expense Royalty Expense January Common Warrants January Common Warrants [Member] January Common Warrants Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Other long-term prepaid assets Increase (Decrease) in Other Noncurrent Assets Proceeds from the exercise of common warrants Proceeds from Warrant Exercises Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] RSUs granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Total operating expenses Costs and Expenses RSUs forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Conversion of Convertible Debt Conversion Of Convertible Debt [Member] Conversion Of Convertible Debt Related Party Transaction [Line Items] Related Party Transaction [Line Items] Debt Instrument, Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Schedule of Quantitative Information Regarding Operating Leases Schedule Of Quantitative Information On Operating Leases [Table Text Block] Schedule Of Quantitative Information On Operating Leases Document Quarterly Report Document Quarterly Report Stock issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Total assets Assets, Fair Value Disclosure Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Shares available for future grants (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Options outstanding, weighted average remaining contractual life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Proceeds from secured lines of credit Proceeds from Secured Lines of Credit July Public Offering July Public Offering [Member] Public Offering RSUs granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Options outstanding, total intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Schedule of Prepaid and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Sale of stock, beneficial ownership limitation, percentage Sale Of Stock, Beneficial Ownership Limitation, Percentage Sale Of Stock, Beneficial Ownership Limitation, Percentage Sale of Stock [Axis] Sale of Stock [Axis] Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Warrants, measurement input Warrants and Rights Outstanding, Measurement Input Compensation Amount Outstanding Recovery Compensation Amount Debt instrument, face amount Debt Instrument, Face Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs Recovery of Erroneously Awarded Compensation Disclosure [Line Items] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Outstanding at beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Restricted cash, noncurrent Restricted Cash, Noncurrent Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Employee Stock Employee Stock [Member] Conversion of senior note payable into common stock Stock Issued During Period, Value, Conversion of Convertible Securities Accrued interest Accrued Interest Premium For Convertible Preferred Stock Accrued Interest Premium For Convertible Preferred Stock Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Purchase of Warrants Purchase Of Warrants [Member] Purchase Of Warrants Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Liability Class [Axis] Liability Class [Axis] Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair value of common stock warrants upon settlement Fair Value Of Common Stock Warrants Upon Settlement Fair Value Of Common Stock Warrants Upon Settlement Minimum Minimum [Member] Number of shares of common stock to purchase (up to) (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment July 2024 Public Offering July 2024 Public Offering [Member] Public Offering Company Selected Measure Name Company Selected Measure Name Debt Debt Disclosure [Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Accrued interest Interest Payable Operating cash outflows from operating leases Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock, $0.01 par value per share; 300,000,000 shares authorized; 18,654,350 shares and 17,814,762 shares issued at March 31, 2026 and December 31, 2025, respectively; 18,639,895 and 17,800,307 outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Weighted average common shares and pre-funded warrants outstanding, diluted (in shares) Weighted average of common shares and pre-funded warrants outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies - Note 9 Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Issuance of common stock and warrants from the January Offering (in shares) Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants Entity Small Business Entity Small Business Income Tax Disclosure [Abstract] Entity Transition Report Document Transition Report 2024 Registration Statement 2024 Registration Statement [Member] 2024 Registration Statement Underlying Securities Award Underlying Securities Amount Pre-Funded Warrant July 2024 Pre-Funded Warrants Pre-Funded Warrant [Member] Pre-Funded Warrant Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date Project [Axis] Project [Axis] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] July Common Warrants July 2024 Common Warrants July Common Warrants [Member] July Common Warrants Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] January 2025 Public Offering January Public Offering [Member] January Public Offering Grant income Grant Revenue, Nonoperating Grant Revenue, Nonoperating Scenario [Axis] Scenario [Axis] Conversion of Convertible Note and interest into equity Settlement Of Promissory Notes Payable Settlement Of Promissory Notes Payable Options vested and exercisable, weighted average remaining contractual life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Operating lease liabilities Increase (Decrease) in Operating Lease Liability Amortization of debt discount Other expense related to accretion of discount Amortization of Debt Discount (Premium) Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] All Individuals All Individuals [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] January 2025 Common Warrants January 2025 Common Warrants [Member] January 2025 Common Warrants 2026 ATM Program 2026 ATM Program [Member] 2026 ATM Program Components of cash and cash equivalents, and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Grant award Research And Development Arrangement, Grant Research And Development Arrangement, Grant Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] At-the-Market Offering At-the-Market Offering [Member] At-the-Market Offering Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract] Research Grant Agreement with GIRF Sept. 2023 Research Grant Agreement With The Gastro-Intestinal Research Foundation (“GIRF”) Sept. 2023 [Member] Research Grant Agreement With The Gastro-Intestinal Research Foundation (“GIRF”) Sept. 2023 Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities Liabilities, Current [Abstract] Stock Option Activity, Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Geographical [Axis] Geographical [Axis] Research Grant Agreement with GIRF Aug. 2024 Research Grant Agreement With The Gastro-Intestinal Research Foundation (“GIRF”) August 2024 [Member] Research Grant Agreement With The Gastro-Intestinal Research Foundation (“GIRF”) August 2024 Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Prepaid research and development contract services Prepaid Research And Development Expenses Prepaid Research And Development Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Warrant liabilities Warrants, Fair Value Disclosure Warrants, Fair Value Disclosure Foreign exchange transaction gain Gain (Loss), Foreign Currency Transaction, before Tax Other prepaid expenses and other current assets Other Prepaid Expenses And Other Assets, Current Other Prepaid Expenses And Other Assets, Current Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Table] Net loss per common share, diluted (in dollars per share) Net loss per share, diluted (in dollars per share) Earnings Per Share, Diluted Forecast Forecast [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Title of 12(b) Security Title of 12(b) Security Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Prepaid insurance Prepaid Insurance Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Shares sold in offering (in shares) Shares issued of common stock (in shares) Sale of Stock, Number of Shares Issued in Transaction Treasury stock, shares outstanding (in shares) Treasury stock, beginning balance (in shares) Treasury stock, ending balance (in shares) Treasury Stock, Common, Shares Earnings Per Share [Abstract] Total other expense, net Nonoperating Income (Expense) Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Senior Secured Convertible Promissory Note Senior Secured Convertible Promissory Note [Member] Senior Secured Convertible Promissory Note Deferred research obligation Increase (Decrease) in Contract with Customer, Liability Less present value discount Lessee, Operating Lease, Liability, Undiscounted Excess Amount Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Award Timing Disclosures [Line Items] Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Accrued compensation and benefits Employee-related Liabilities, Current Total Lessee, Operating Lease, Liability, to be Paid RSUs exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Common Stock and Stockholders' Equity Equity [Text Block] Sale of stock, aggregate initial offering price Sale of Stock, Aggregate Initial Offering Price Sale of Stock, Aggregate Initial Offering Price Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Subsequent Event [Table] Subsequent Event [Table] Expiration Date Trading Arrangement Expiration Date Warrants Warrants And Rights Outstanding [Text Block] Warrants And Rights Outstanding March 2024 Pre-Funded Warrants March 2024 Pre-Funded Warrants [Member] March 2024 Pre-Funded Warrants Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Research Grant Agreement with GIRF Sept. 2022 Research Grant Agreement With The Gastro-Intestinal Research Foundation (“GIRF”) Sept. 2022 [Member] Research Grant Agreement With The Gastro-Intestinal Research Foundation (“GIRF”) Sept. 2022 Adoption Date Trading Arrangement Adoption Date Price per share of shares issued (in dollars per share) Shares Issued, Price Per Share Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Chemistry, manufacturing and controls expenses Translational Medicine and CMC [Member] Translational Medicine and CMC Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Proceeds from issuance of common stock and common warrants from the January 2025 Offering Proceeds from Convertible Debt Loss from operations Operating Income (Loss) Accumulated deficit Retained Earnings (Accumulated Deficit) The 2022 Plan The 2022 Plan [Member] The 2022 Plan July Pre-Funded Warrants July Pre-Funded Warrants [Member] July Pre-Funded Warrants Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Class of Stock [Axis] Class of Stock [Axis] Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Current Fiscal Year End Date Current Fiscal Year End Date Subsequent Event Type [Domain] Subsequent Event Type [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Other accrued expenses Accrued Other Operating Liabilities, Current Accrued Other Operating Liabilities, Current Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted average grant date fair value (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Commitments and Contingencies Disclosure [Table] Commitments and Contingencies Disclosure [Table] Commitments and Contingencies Disclosure Risk-free rate Measurement Input, Risk Free Interest Rate [Member] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Description of the Business and Financial Condition Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Antidilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Amendment Flag Amendment Flag Share price (in dollars per share) Sale of Stock, Price Per Share Shares authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Treasury stock, at cost, 14,455 shares outstanding Treasury Stock, Common, Value Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Weighted-average discount rate—operating leases Operating Lease, Weighted Average Discount Rate, Percent Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Outstanding Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Issuance of common stock upon settlement of restricted stock and common warrants Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Weighted average common shares and pre-funded warrants outstanding, basic (in shares) Weighted average of common shares and pre-funded warrants outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Warrants and rights outstanding Warrants and Rights Outstanding Schedule of Net Loss Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Related Party Transaction [Domain] Related Party Transaction [Domain] Options vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Subsequent Events [Abstract] Segment Reporting [Abstract] Segment Reporting [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Operating lease, expense Operating Lease, Expense Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Conversion of senior note payable Amortization of Debt Issuance Costs Entity Tax Identification Number Entity Tax Identification Number Scenario [Domain] Scenario [Domain] Issuance of common stock and warrants from the January Offering Issuance of Stock and Warrants for Services or Claims Outstanding at beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted-average remaining lease term—operating leases (in years) Operating Lease, Weighted Average Remaining Lease Term Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Subsequent Events Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Forfeited (unvested) (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Issuance of common stock, net of issuance costs Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Consideration received net of sales commissions Sale of Stock, Consideration Received on Transaction, Net Of Sales Commissions Sale of Stock, Consideration Received on Transaction, Net Of Sales Commissions Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Counterparty Name [Axis] Counterparty Name [Axis] Schedule of Restricted Stock Unit, Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Subsequent Event [Line Items] Subsequent Event [Line Items] The 2021 Plan The 2021 Plan [Member] The 2021 Plan Non-cash interest expense Interest Expense, Noncash Interest Expense, Noncash Common Stock Common Stock [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Accrued professional fees Accrued Professional Fees, Current